Public-Private Partnerships in Biobanking: Current Practices
- Authors: Manuel M. Morente1, Francisco de Luna2, Maria C. Marín3, Nuria Ajenjo4
-
View Affiliations Hide Affiliations1 Spanish National Cancer Research Centre (CNIO), Calle Melchor Fernandez Almagro, 3. 28029 Madrid, Spain 2 Spanish National Cancer Research Centre (CNIO), Calle Melchor Fernandez Almagro, 3. 28029 Madrid, Spain 3 Spanish National Cancer Research Centre (CNIO), Calle Melchor Fernandez Almagro, 3. 28029 Madrid, Spain 4 Spanish National Cancer Research Centre (CNIO), Calle Melchor Fernandez Almagro, 3. 28029 Madrid, Spain
- Source: Advances in Biobanking Practice Through Public and Private Collaborations , pp 1-11
- Publication Date: July 2017
- Language: English
Public-Private Partnerships in Biobanking: Current Practices, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9781681085104/chapter-1-1.gif
Public-private partnerships (PPPs) and relationships are essential to expedite the resolution of the challenges currently facing Medicine. Biobanking is not an island within biomedical research as a whole, and publicprivate partnerships in biobanking must therefore be considered in the global context of biomedical research. PPPs are certainly desirable, since they offer benefits to both sides, create win-win situations and are extremely advantageous for the whole society, but they have their own limitations and frontiers. The current chapter tries to introduce the general aspects of current PPP practices in biobanking, keeping in mind that the main objective should be the promotion of health rather than the sustainability of biobanks or benefits for industry. Compliance with applicable legislation, mutual trust, transparency and open dialogue are the key components of such partnerships.
-
From This Site
/content/books/9781681085104.chapter-1dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
